Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and ...

Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...

LyfeSci Research & Innovation, a full-service clinical research organization (CRO), announces the acquisition of Clinically Media, a patient recruitment company specializing in data-driven, inclusive ...

Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most ...

The funding will enable further international expansion, as well as development of the company’s Omnichannel partner ...

Aided by AI and better EHRs, healthcare leaders are integrating clinical trial recruitment into care management and ...

One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical ...

SubjectWell, founded in 2012 to connect patients with clinical trials, now positions itself as a global Patient Experience Platform serving sponsors, contract research organizations (CROs), and ...

This guidance document, outlines Health Canada's expectations for sponsors of clinical trials involving drugs, and provides direction on voluntary the submission of a Sex- and Gender-Based Analysis ...

The tool’s primary application is to accelerate and improve the accuracy of patient screening for clinical trials.

Breast cancer is the most-researched disease, yet only 14% of trials reach optimal enrollment, highlighting a significant gap in clinical trial participation. COVID-19 has increased trial attrition ...